Similarly, the eIF4G-binding compound SBI-756 disrupts formation of eIF4F and promotes dasatinib-mediated killing of mouse p190 cells and Ph+ or Ph-like B-ALL cells. This evidence concerns the gene EIF4G1 and acute lymphoblastic leukemia.